ClassID:

95253

C07D403/14 - page 5 - CPC Classification

Classification description:

Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing three or more hetero rings

Recent Application in this class:
#1201
20220009906
2022-01-13

ISOINDOLIN-1-ONE DERIVATIVES USEFUL AS GRK2 INHIBITORS

#1202
20220009903
2022-01-13

Anti-viral compounds

#1203
20220002314
2022-01-06

PIPERAZINYL AND PIPERIDINYL QUINAZOLIN-4(3H)-ONE DERIVATIVES HAVING ACTIVITY AGAINST PAIN

#1204
20220002278
2022-01-06

HISTONE ACETYLTRANSFERASE (HAT) INHIBITOR AND USE THEREOF

#1205
20220002275
2022-01-06

ENZYME INHIBITORS

#1206
20220002274
2022-01-06

3,4,5-trisubstituted-1,2,4-triazoles and 3,4,5-trisubstituted-3-thio-1,2,4-triazoles and uses thereof

#1207
20220002273
2022-01-06

Cereblon binding compounds, compositions thereof, and methods of treatment therewith

#1208
20220002271
2022-01-06

Heterocyclic inhibitors of PCSK9

#1209
20220002270
2022-01-06

Tetrazole derivatives as TRPA1 inhibitors

#1210
20220002269
2022-01-06

Compounds for the treatment of respiratory diseases

#1211
20220002266
2022-01-06

RHO-ASSOCIATED PROTEIN KINASE INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF

#1212
20220000890
2022-01-06

Inhibitors of cyclin dependent kinase 7 (CDK7)

#1213
20210403465
2021-12-30

QUINAZOLINYL-INDAZOLE DERIVATIVES AND THEIR USE AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

#1214
20210399232
2021-12-23

Compound and organic light emitting device comprising the same

#1215
20210399230
2021-12-23

Organic molecules for optoelectronic devices

#1216
20210395262
2021-12-23

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

#1217
20210395234
2021-12-23

Indazole compound or salt thereof

#1218
20210395233
2021-12-23

Compound and organic electroluminescence device

#1219
20210395231
2021-12-23

Receptor inhibitors, pharmaceutical compositions comprising the same and use thereof

#1220
20210395230
2021-12-23

EGFR inhibitor compounds

#1221
20210393633
2021-12-23

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

#1222
20210391544
2021-12-16

Cyclic compound and organic light emitting device comprising same

#1223
20210387969
2021-12-16

Bicyclic aza compounds as muscarinic Mand/or Mreceptor agonists

#1224
20210386721
2021-12-16

SUBSTITUTED PHENYLPROPENYL PYRIDINE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL APPLICATIONS

#1225
20210380563
2021-12-09

Processes of preparing a JAK1 inhibitor

#1226
20210380562
2021-12-09

Compounds

#1227
20210380537
2021-12-09

PYRAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO

#1228
20210379071
2021-12-09

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

#1229
20210379064
2021-12-09

AXL INHIBITORS FOR USE IN COMBINATION THERAPY FOR PREVENTING, TREATING OR MANAGING METASTATIC CANCER

#1230
20210371400
2021-12-02

SMAC mimetics used as IAP inhibitors and use thereof

#1231
20210369710
2021-12-02

MODULATORS OF MYC FAMILY PROTO-ONCOGENE PROTEIN

#1232
20210363132
2021-11-25

Compound and organic light emitting device comprising the same

#1233
20210363130
2021-11-25

Heterocyclic compound

#1234
20210359223
2021-11-18

ORGANIC LIGHT-EMITTING ELEMENT

#1235
20210359217
2021-11-18

Compound, material for organic electroluminescent element, organic electroluminescent element, and electronic device

#1236
20210359215
2021-11-18

COMPOUND AND LIGHT-EMITTING DEVICE INCLUDING THE SAME

#1237
20210355378
2021-11-18

HETEROCYCLIC COMPOUNDS EXHIBITING THERMALLY ACTIVATED DELAYED FLUORESCENCE (TADF) AND THEIR USE IN ELECTROLUMINESCENT DEVICES

#1238
20210355128
2021-11-18

Compound and organic light emitting device comprising the same

#1239
20210355112
2021-11-18

Modulators of THR-β and methods of use thereof

#1240
20210355111
2021-11-18

Inhibitors of cysteine proteases and methods of use thereof

#1241
20210355110
2021-11-18

THYROID HORMONE RECEPTOR AGONISTS

#1242
20210355105
2021-11-18

REGULATOR OF NITROGEN-CONTAINING HETEROAROMATIC DERIVATIVES, PREPARATION METHOD THEREFOR AND USE THEREOF

#1243
20210347764
2021-11-11

Use of AURKB small-molecule inhibitors for treatment of non-small cell lung cancer

#1244
20210347763
2021-11-11

BIARYL PIPERIDINE AMIDE COMPOUNDS AND METHODS OF USE THEREOF

#1245
20210347762
2021-11-11

Carbocyclic prolinamide derivatives

#1246
20210347756
2021-11-11

INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR

#1247
20210346395
2021-11-11

Inhibitors of EGFR and methods of use thereof

#1248
20210346353
2021-11-11

CD73 inhibitors

#1249
20210340135
2021-11-04

Inhibiting agents for Bruton's tyrosine kinase

#1250
20210338850
2021-11-04

Triazine based radiopharmaceuticals and radioimaging agents

#1251
20210338841
2021-11-04

Imaging Agents

#1252
20210332034
2021-10-28

GLP-1 receptor agonists and uses thereof

#1253
20210332032
2021-10-28

Benzonitrile derivative, light-emitting material, and light-emitting element using same

#1254
20210332031
2021-10-28

Multi-aziridine compound

#1255
20210332029
2021-10-28

Isoindolin-1-on derivative, method for preparing same, and pharmaceutical composition comprising same as effective component for preventing or treating cancer

#1256
20210328155
2021-10-21

Electron buffering material and organic electroluminescent device comprising the same

#1257
20210322413
2021-10-21

Nitric oxide releasing phosphodiesterase type 5 inhibitor

#1258
20210322409
2021-10-21

METALLOENZYME INHIBITOR COMPOUNDS

#1259
20210317108
2021-10-14

Organic molecules for optoelectronic devices

#1260
20210317082
2021-10-14

Diamine compound, polyimide precursor using same, and polyimide film

#1261
20210315893
2021-10-14

NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROSIS

#1262
20210309653
2021-10-07

Phenoxytriazoles

#1263
20210309644
2021-10-07

Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors

#1264
20210309614
2021-10-07

5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis

#1265
20210309610
2021-10-07

NLRX1 ligands

#1266
20210305520
2021-09-30

Electroluminescent devices

#1267
20210300935
2021-09-30

PYRAZOLO-QUINAZOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS KINASE INHIBITORS

#1268
20210300919
2021-09-30

Compounds and compositions for inhibiting the activity of SHP2

#1269
20210300914
2021-09-30

Substituted pyrimidines as LRKK2 inhibitors

#1270
20210300906
2021-09-30

Pyrazole derivatives as H4 antagonist compounds

#1271
20210300904
2021-09-30

Inhibitors of RAF kinases

#1272
20210300900
2021-09-30

OGA INHIBITOR COMPOUNDS

#1273
20210299126
2021-09-30

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

#1274
20210292313
2021-09-23

Substituted phenazines and methods of treating cancer and bacterial diseases

#1275
20210292305
2021-09-23

Cyclic Ureas

#1276
20210292301
2021-09-23

Heteroaromatic carboxamide derivatives as plasma kallikrein inhibitors

#1277
20210292285
2021-09-23

HETEROCYCLIC COMPOUNDS AS ADENOSINE ANTAGONISTS

#1278
20210292281
2021-09-23

Pyrazole and imidazole compounds for inhibition of IL-17 and RORgamma

#1279
20210284645
2021-09-16

COMPOSITIONS USEFUL FOR TREATING DISORDERS RELATED TO KIT

#1280
20210284629
2021-09-16

METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE

#1281
20210284627
2021-09-16

INDOLE COMPOUNDS AND PHARMACEUTICAL USE THEREOF

#1282
20210283138
2021-09-16

Substituted indole Mcl-1 inhibitors

#1283
20210276979
2021-09-09

Substituted pyrimidine compounds as multifunctional radical quenchers and their uses

#1284
20210276976
2021-09-09

Heteroaromatic carboxamide derivatives as plasma kallikrein inhibitors

#1285
20210275526
2021-09-09

Methods for treating Huntington's disease

#1286
20210275525
2021-09-09

Pharmaceutical compounds

#1287
20210273177
2021-09-02

Organic electroluminescence device and compound for organic electroluminescence device

#1288
20210273164
2021-09-02

Compound for organic electric element, organic electric element using the same, and electronic device thereof

#1289
20210269458
2021-09-02

ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS

#1290
20210269424
2021-09-02

Pyrimidine derivative and preparation process and use thereof

#1291
20210269419
2021-09-02

1,2,4-triazole derivatives as tankyrase inhibitors

#1292
20210267971
2021-09-02

2,4-PYRIMIDINEDIAMINE COMPOUNDS AND THEIR USES

#1293
20210261559
2021-08-26

1,5-disubstituted 1,2,3-triazoles are inhibitors of Rac/Cdc42 GTPases

#1294
20210261552
2021-08-26

ERK inhibitor and use thereof

#1295
20210261543
2021-08-26

PYRIMIDINE OR PYRIDINE COMPOUNDS, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USES THEREOF

#1296
20210261532
2021-08-26

Modulators of RAS GTPase

#1297
20210261531
2021-08-26

Nitrogen-heterocyclic compound, display panel and display apparatus

#1298
20210260027
2021-08-26

METHODS FOR TREATING PULMONARY EMPHYSEMA USING SUBSTITUTED 2-AZA-BICYCLO[2.2.1]HEPTANE-3-CARBOXYLIC ACID (BENZYL-CYANO-METHYL)-AMIDES INHIBITORS OF CATHEPSIN C

#1299
20210257558
2021-08-19

Compound For Organic Electronic Element, Organic Electronic Element Using Same, And Electronic Device Thereof

#1300
20210253575
2021-08-19

PYRROLIDINE AMINE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE

#1301
20210253559
2021-08-19

Pyrrolidine compounds

#1302
20210253556
2021-08-19

Inhibitors of ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) and methods of use thereof

#1303
20210251991
2021-08-19

SUBSTITUTED 2,2'-BIPYRIMIDINYL COMPOUNDS, ANALOGUES THEREOF, AND METHODS USING SAME

#1304
20210246133
2021-08-12

INDOLIN-2-ONE OR PYRROLO -PYRIDIN -2 -ONE DERIVATIVES

#1305
20210246122
2021-08-12

Triazine Compounds and Uses Thereof

#1306
20210238226
2021-08-05

METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE

#1307
20210238168
2021-08-05

Bipyrazole derivatives as JAK inhibitors

#1308
20210238167
2021-08-05

SMALL MOLECULE IRE1-ALPHA INHIBITORS

#1309
20210236505
2021-08-05

SUBSTITUTED QUINOXALINE DNA-PK INHIBITORS

#1310
20210236495
2021-08-05

Compounds and Their Use for Reducing Uric Acid Levels

#1311
20210230174
2021-07-29

Spirocyclic tetrahydroquinazolines

#1312
20210230143
2021-07-29

Cyclohexyl acid triazole azines as LPA antagonists

#1313
20210230126
2021-07-29

ASYMMETRIC TRIAZOLE BENZAMIDE DERIVATIVES AND THE COMPOSITIONS AND METHODS OF TREATMENT REGARDING THE SAME

#1314
20210230115
2021-07-29

Antibacterial compounds

#1315
20210226132
2021-07-22

ORGANIC ELECTROLUMINESCENT ELEMENT

#1316
20210226127
2021-07-22

Compound for organic electric element, organic electric element using the same, and electronic device thereof

#1317
20210221798
2021-07-22

HIGH RELAXIVITY GADOLINIUM CHELATE COMPOUNDS FOR USE IN MAGNETIC RESONANCE IMAGING

#1318
20210221797
2021-07-22

Pyrimidine derivative, method for preparing same and use thereof in medicine

#1319
20210221796
2021-07-22

Antibacterial compounds

#1320
20210221793
2021-07-22

PYRAZOLE DERIVATIVES AS SGC STIMULATORS

#1321
20210221775
2021-07-22

Materials for organic electroluminescent devices

#1322
20210217966
2021-07-15

Materials for organic electroluminescent devices

#1323
20210214364
2021-07-15

sGC STIMULATORS

#1324
20210214346
2021-07-15

Quinazoline-pyrazole derivatives for the treatment of cancer-related disorders

#1325
20210214345
2021-07-15

Inhibitors of human immunodeficiency virus replication

#1326
20210214344
2021-07-15

JAK3 selective inhibitor

#1327
20210214342
2021-07-15

Amide compounds and method for making and using

#1328
20210214338
2021-07-15

1,3-dipolar cycloadditions, and Staudinger ligations for conjugating biomolecules using click chemistry

#1329
20210214321
2021-07-15

NOVEL REACTIVE BENZOTRIAZOLE UV ABSORBER AND USE THEREOF

#1330
20210204547
2021-07-08

Benzimidazole compounds as agricultural chemicals

#1331
20210198277
2021-07-01

AMINE-SUBSTITUTED ARYL OR HETEROARYL COMPOUNDS

#1332
20210198252
2021-07-01

SMYD INHIBITORS

#1333
20210198239
2021-07-01

COMPOUNDS AND METHODS FOR CD73 MODULATION AND INDICATIONS THEREFOR

#1334
20210188863
2021-06-24

Indazolyl-spiro[2.2]pentane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof

#1335
20210188860
2021-06-24

3-((Hetero-)Aryl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives

#1336
20210188841
2021-06-24

Analgesic drug using PAC1 receptor antagonistic drug

#1337
20210188827
2021-06-24

ATM kinase inhibitors and compositions and methods of use thereof

#1338
20210188821
2021-06-24

JAK1 selective inhibitors

#1339
20210188820
2021-06-24

Antagonists of the muscarinic acetylcholine receptor M4

#1340
20210188819
2021-06-24

Organic molecules for use in optoelectronic devices

#1341
20210188818
2021-06-24

Indazolyl-spiro[2.3]hexane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof

#1342
20210188816
2021-06-24

Heterocyclic compound, organic light emitting diode comprising same, composition for organic layer of organic light emitting diode, and method for manufacturing organic light emitting diode

#1343
20210188810
2021-06-24

Heteroaryl inhibitors of PAD4

#1344
20210188802
2021-06-24

Proteasome activity enhancing compounds

#1345
20210188783
2021-06-24

Substituted benzimidazoles as inhibitors of transforming growth factor-β kinase

#1346
20210184134
2021-06-17

Organic molecules for use in organic devices

#1347
20210184132
2021-06-17

Compound, composition including the same, liquid composition, and organic electroluminescent device

#1348
20210181637
2021-06-17

Material for forming organic film, method for forming organic film, patterning process, and compound

#1349
20210179597
2021-06-17

Water soluble novel cyanine fluorophore with tunable properties between near IR and SWIR region for in vivo imaging

#1350
20210179591
2021-06-17

NEW COMPOUNDS FOR USE AS A THERAPEUTICALLY ACTIVE SUBSTANCE AND IN PARTICULAR FOR USE IN THE TREATMENT OF TUMORS

#1351
20210179590
2021-06-17

Substituted triazole derivatives and uses thereof

#1352
20210179556
2021-06-17

PRIMARY CARBOXAMIDES AS BTK INHIBITORS

#1353
20210175434
2021-06-10

Organic molecules for use in organic optoelectronic devices

#1354
20210171519
2021-06-10

Methods and compositions for modulating splicing

#1355
20210171509
2021-06-10

Matrix metalloproteinase (MMP) inhibitors and methods of use thereof

#1356
20210171506
2021-06-10

Process for Manufacturing Pibrentasvir Active Drug Substance

#1357
20210171502
2021-06-10

Methods and composition of 4-substituted benzoylpiperazine-1-substituted carbonyls as beta-catenin/B-cell lymphoma 9 inhibitors

#1358
20210169894
2021-06-10

Tropomyosin-related kinase (TRK) inhibitors

#1359
20210163470
2021-06-03

Cyclohexyl acid triazole azoles as LPA antagonists

#1360
20210163466
2021-06-03

EP4 antagonist

#1361
20210161912
2021-06-03

Peripherally-restricted dual-acting kappa and delta opioid agonist for analgesia in pain states involving the inflammatory response

#1362
20210155634
2021-05-27

Tryptophan hydroxylase inhibitor and pharmaceutical composition including same

#1363
20210155609
2021-05-27

Pyrazolylacylpyrazoline compounds and method for treating pain

#1364
20210155608
2021-05-27

Heteroaryl-triazole and heteroaryl-tetrazole compounds as pesticides

#1365
20210151683
2021-05-20

LIGHT-EMITTING ELEMENT, AND DISPLAY, ILLUMINATOR, AND SENSOR EACH INCLUDING SAME

#1366
20210147436
2021-05-20

Pyrrolidinyl urea derivatives and application thereof in TrkA-related diseases

#1367
20210147430
2021-05-20

Pyrrolotriazine compounds as TAM inhibitors

#1368
20210147403
2021-05-20

SUBSTITUTED PYRROLIDINES AS FACTOR XIA INHIBITORS FOR THE TREATMENT THROMBOEMBOLIC DISEASES

#1369
20210147393
2021-05-20

DIFLUOROMETHYL-PHENYL TRIAZOLES

#1370
20210147391
2021-05-20

RHO KINASE INHIBITORS

#1371
20210147388
2021-05-20

Imidazolyl kinase inhibitors and uses thereof

#1372
20210147386
2021-05-20

Pyrrolidine and piperidine compounds

#1373
20210147382
2021-05-20

Benzimidazolone derived inhibitors of BCL6

#1374
20210147368
2021-05-20

Aryl or heteroaryl triazolone derivatives or salts thereof, or pharmaceutical compositions comprising the same

#1375
20210145831
2021-05-20

Crystalline forms of 5-bromo-2,6-di(1H-pyrazol-1- yl)pyrimidin-4-amine and new salts

#1376
20210145824
2021-05-20

MODULATORS OF CELLULAR ADHESION

#1377
20210139505
2021-05-13

PIKfyve inhibitors

#1378
20210139494
2021-05-13

Heterocyclic RIP1 inhibitory compounds

#1379
20210139473
2021-05-13

Heterocyclic amides useful as protein modulators

#1380
20210139472
2021-05-13

Ferroportin inhibitors

#1381
20210139465
2021-05-13

Prodigiosin Analogs And Methods Of Use

#1382
20210139464
2021-05-13

Pyrimidine derivative containing one deuterium atom and preparation process and use thereof

#1383
20210139453
2021-05-13

(HETERO)ARYL SULFONAMIDE COMPOUND AND FORMULATION FOR CONTROLLING HARMFUL ORGANISMS

#1384
20210135119
2021-05-06

COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES

#1385
20210135118
2021-05-06

Organic compound and organic electroluminescent device using the same

#1386
20210130343
2021-05-06

Compositions and methods for inhibiting kinases

#1387
20210130342
2021-05-06

Pyridazinones as PARP7 inhibtors

#1388
20210130340
2021-05-06

Inhibitors of cyclin-dependent kinases

#1389
20210130338
2021-05-06

Heparanase inhibitors and use thereof

#1390
20210130327
2021-05-06

Pyridazinone compounds and uses thereof

#1391
20210130325
2021-05-06

Heteroaryl-biphenyl amides for the treatment of PD-L1 diseases

#1392
20210128668
2021-05-06

Tetramaleimide linkers and use thereof

#1393
20210128532
2021-05-06

Heterocyclic carboxylate compounds as glycolate oxidase inhibitors

#1394
20210122749
2021-04-29

Bicyclic heterocycle compounds and their uses in therapy

#1395
20210122744
2021-04-29

GLS1 inhibitors for treating disease

#1396
20210122733
2021-04-29

Amino compounds for treatment of immune and inflammatory disorders

#1397
20210115034
2021-04-22

Amide compounds for treatment of immune and inflammatory disorders

#1398
20210115023
2021-04-22

KDM1A inhibitors for the treatment of disease

#1399
20210115022
2021-04-22

Thyroid hormone receptor agonists and uses thereof

#1400
20210111351
2021-04-15

MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES

#1401
20210109090
2021-04-15

Protease-activated contrast agents for in vivo imaging

#1402
20210101906
2021-04-08

BIOACTIVE CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF

#1403
20210101903
2021-04-08

Compounds and pharmaceutical compositions thereof for the treatment of diseases

#1404
20210101891
2021-04-08

Histone acetyltransferase (HAT) inhibitor and use thereof

#1405
20210101886
2021-04-08

Substituted benzenecarboxamides as IL-17A modulators

#1406
20210101883
2021-04-08

ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME

#1407
20210101882
2021-04-08

Fluorine-substituted indazole compounds and uses thereof

#1408
20210101881
2021-04-08

PYRIMIDINE COMPOUND, PREPARATION METHOD THEREOF AND MEDICAL USE THEREOF

#1409
20210101880
2021-04-08

Azolopyrimidine for the treatment of cancer-related disorders

#1410
20210098712
2021-04-01

Compound, display panel, and display apparatus

#1411
20210098710
2021-04-01

Compound, organic electroluminescent device and display equipment

#1412
20210098707
2021-04-01

Organic electroluminescent element, electronic device, and compound

#1413
20210094935
2021-04-01

Bicyclic heterocycles as FGFR inhibitors

#1414
20210094934
2021-04-01

Carboxamide compounds and uses thereof

#1415
20210094921
2021-04-01

Inhibitors of receptor interacting protein kinase I for the treatment of disease

#1416
20210094913
2021-04-01

INHIBITORS OF EGFR AND METHODS OF USE THEREOF

#1417
20210093636
2021-04-01

Arylamide compounds and compositions and uses thereof

#1418
20210093613
2021-04-01

Diazole lactams

#1419
20210087182
2021-03-25

Substituted cyanoindoline derivatives as NIK inhibitors

#1420
20210087180
2021-03-25

Modulators of STING (stimulator of interferon genes)

#1421
20210087179
2021-03-25

COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE

#1422
20210087178
2021-03-25

Cyclohexyl acid pyrazole azines as LPA antagonists

#1423
20210087172
2021-03-25

FACTOR XIIa INHIBITORS

#1424
20210087167
2021-03-25

ASK1 INHIBITOR COMPOUNDS AND USES THEREOF

#1425
20210086164
2021-03-25

Irreversible covalent organic framework for efficient and selective gold recovery and preparation method thereof

#1426
20210078986
2021-03-18

INHIBITORS FOR THE B-CATENIN/B-CELL LYMPHOMA 9 (BCL9) PROTEIN-PROTEIN INTERACTION

#1427
20210078982
2021-03-18

Cyclohexyl acid pyrazole azoles as LPA antagonists

#1428
20210078981
2021-03-18

Compounds and methods for inhibiting JAK

#1429
20210078978
2021-03-18

Benzoimidazoles as prolyl hydroxylase inhibitors

#1430
20210078977
2021-03-18

Pyrimidines as EGFR inhibitors and methods of treating disorders

#1431
20210078959
2021-03-18

HIV protease inhibitors

#1432
20210078947
2021-03-18

Therapeutic compounds and methods of use thereof

#1433
20210077489
2021-03-18

2-substituted pyrazole amino-4-substituted amino-5-pyrimidine formamide compound, composition, and application thereof

#1434
20210074941
2021-03-11

ORGANIC ELECTROLUMINESCENCE DEVICE

#1435
20210074926
2021-03-11

Compound For Organic Electronic Element, Organic Electronic Element Using Same, And Electronic Device Thereof

#1436
20210070767
2021-03-11

Apelin receptor (APJ) agonists and uses thereof

#1437
20210070752
2021-03-11

HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS

#1438
20210070744
2021-03-11

Heterocyclic RIP1 kinase inhibitors

#1439
20210070743
2021-03-11

RIP1 inhibitory compounds and methods for making and using the same

#1440
20210070739
2021-03-11

2-benzopyrazinyl-n-heteroaryl-2-phenyl-acetamide compounds

#1441
20210070735
2021-03-11

RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME

#1442
20210069203
2021-03-11

DNA-PK inhibitors

#1443
20210066614
2021-03-04

Organic electroluminescent materials and devices

#1444
20210062251
2021-03-04

Enhancement of nucleic acid polymerization by aromatic compounds

#1445
20210061812
2021-03-04

7-membered aza-heterocyclic containing δ-opioid receptor modulating compounds, methods of using and making the same

#1446
20210061791
2021-03-04

Reactive oxygen species scavengers and use for treating diseases

#1447
20210061790
2021-03-04

5-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same

#1448
20210061768
2021-03-04

2-substituted amino-naphth (1,2-d) imidazol-5-one compounds of pharmaceutically acceptable salts thereof

#1449
20210053986
2021-02-25

Cyano cyclobutyl compounds for CBL-B inhibition and uses thereof

#1450
20210053974
2021-02-25

Inhibitors of the menin-MLL interaction

#1451
20210053960
2021-02-25

Pyrazole MAGL inhibitors

#1452
20210053946
2021-02-25

PD-1/PD-L1 inhibitors

#1453
20210053945
2021-02-25

Acryloyl-containing nuclear transport regulators and uses thereof

#1454
20210052576
2021-02-25

Tetrahydroisoquinoline derivatives, preparation process and use thereof

#1455
20210050527
2021-02-18

Organic compound, and organic light emitting diode and organic light emitting display device including the same

#1456
20210047560
2021-02-18

HETEROCYCLIC COMPOUNDS EXHIBITING THERMALLY ACTIVATED DELAYED FLUORESCENCE (TADF) AND THEIR USE IN ELECTROLUMINESCENT DEVICES

#1457
20210047304
2021-02-18

Bromodomain Inhibitors

#1458
20210047300
2021-02-18

Hetero ring-fused phenyl compounds for inhibiting TNIK and medical uses thereof

#1459
20210046070
2021-02-18

Lanthionine synthetase C-like 2-based therapeutics

#1460
20210043847
2021-02-11

Hole transporting material, method for preparing same, and electroluminescent device

#1461
20210040088
2021-02-11

Inhibitors of EGFR and methods of use thereof

#1462
20210040081
2021-02-11

Indole derivatives as estrogen receptor degraders

#1463
20210040071
2021-02-11

Solid forms of an HPK1 inhibitor

#1464
20210040070
2021-02-11

Pyrazine-2(1H)-ketone compound acting as FGFR inhibitor

#1465
20210040067
2021-02-11

Pharmaceutical compounds

#1466
20210040038
2021-02-11

NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME

#1467
20210038606
2021-02-11

Modulators of Rho-associated protein kinase

#1468
20210032269
2021-02-04

Sting agonist compounds and methods of use

#1469
20210032267
2021-02-04

Cyanoindoline derivatives as NIK inhibitors

#1470
20210032256
2021-02-04

3-((Hetero-)Aryl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives

#1471
20210032234
2021-02-04

Pyrazol-3-ones that activate pro-apoptotic BAX

#1472
20210032225
2021-02-04

Organic electroluminescent materials and devices

#1473
20210032224
2021-02-04

Heteroaryl[4,3-C]pyrimidine-5-amine derivative, preparation method therefor, and medical uses thereof

#1474
20210032222
2021-02-04

Five-membered ring-substituted pyridazinol compounds and derivatives, preparation methods, herbicidal compositions and applications thereof

#1475
20210024503
2021-01-28

4-oxo-3,4-dihydroquinazoline compounds as inhibitors of human immunodeficiency virus replication

#1476
20210024502
2021-01-28

Pyridazinones as PARP7 inhibitors

#1477
20210024501
2021-01-28

Covalent inhibitors of KRAS

#1478
20210024464
2021-01-28

BINDING FUNCTION 3 (BF3) SITE COMPOUNDS AS THERAPEUTICS AND METHODS FOR THEIR USE

#1479
20210023224
2021-01-28

Branched multi-functional macromonomers and related polymers and uses thereof

#1480
20210023085
2021-01-28

Small molecule inhibitors of EGFR and PI3K

#1481
20210020845
2021-01-21

Compound and organic light-emitting device including the same

#1482
20210017192
2021-01-21

Heterocycle-substituted bicyclic azole pesticides

#1483
20210017166
2021-01-21

PHARMACOKINETICALLY IMPROVED COMPOUNDS

#1484
20210017139
2021-01-21

Inhibitors for the β-catenin / T-cell factor protein-protein interaction

#1485
20210013425
2021-01-14

Carbazole-based compound and organic light emitting diode comprising same

#1486
20210009569
2021-01-14

Synthetic receptors for ionophoric compounds

#1487
20210009568
2021-01-14

Methods and compounds for treating disorders

#1488
20210009567
2021-01-14

HETEROAROMATIC COMPOUNDS AS BTK INHIBITORS

#1489
20210009562
2021-01-14

Anti-cancer compounds

#1490
20210009555
2021-01-14

THERAPEUTIC COMPOUNDS

#1491
20210008023
2021-01-14

N4-phenyl-quinazoline-4 -amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases

#1492
20210005823
2021-01-07

Organic molecules for optoelectronic devices

#1493
20210003921
2021-01-07

COMPOUND, RESIN, COMPOSITION, AND FILM FORMING MATERIAL FOR LITHOGRAPHY USING THE SAME

#1494
20210002288
2021-01-07

Indazole compounds and uses thereof

#1495
20210002263
2021-01-07

HETEROARYLPYRIMIDINE COMPOUND AND FORMULATION FOR CONTROLLING HARMFUL ORGANISMS

#1496
20210002260
2021-01-07

Compounds, compositions, and methods

#1497
20210002233
2021-01-07

PKM2 MODULATORS AND METHODS FOR THEIR USE

#1498
20200411769
2020-12-31

Compound and organic light emitting display device

#1499
20200407353
2020-12-31

GLS1 inhibitors for treating disease

#1500
20200407345
2020-12-31

Compositions and methods for treating infections